Management of moderate to severe psoriasis with brodalumab—Real‐world evidence from the LIBERO study

Ähnliche Einträge

• Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study)
  von: Dimitrios Rigopoulos, et al.
  Veröffentlicht: (2024)
• Real‐world evidence for comprehensive evaluation of guselkumab in the treatment of psoriasis
  von: Diamant Thaçi
  Veröffentlicht: (2025)
• Real‐world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate‐to‐severe plaque psoriasis
  von: Natalia Rompoti, et al.
  Veröffentlicht: (2024)
• Mission impossible? Caveats in interpreting and comparing long‐term efficacy in biologic studies for moderate‐to‐severe plaque psoriasis
  von: Richard G. Langley, et al.
  Veröffentlicht: (2025)
• French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025
  von: Marie Masson Regnault, et al.
  Veröffentlicht: (2025)